Navigation Links
CEM President and CEO Delivers Commencement Address at the 2012 University of Texas at Austin Chemistry and Biochemistry Department Graduation
Date:5/25/2012

MATTHEWS, N.C., May 25, 2012 /PRNewswire/ -- CEM Corporation president and CEO Michael J. Collins delivered the commencement address for the University of Texas at Austin Chemistry and Biochemistry Department, which was held on May 18, 2012. Collins received his PhD in Physical Chemistry from the University and has been a member of the Advisory Board for the Chemistry Department at the school for a number of years.

(Logo: http://photos.prnewswire.com/prnh/20090622/CL35336LOGO-b )

"I am honored to have been asked to deliver the commencement address again this year," said Michael J. Collins. "UT's encouragement of science and innovation has resulted in a thriving chemistry and biochemistry program whose graduates rank at the top of their professions. I enjoyed speaking to this year's graduates and I look forward to the scientific discoveries and contributions they will make in the years to come."

Collins told the audience about his time at the University of Texas at Austin and how it helped shape his life as a chemist, entrepreneur, and business leader. He advised graduates to disregard the defeatists that have been predicting a worsening of the economy and a lack of opportunities.

"I predict we are on the verge of a major new era of growth for the US which will exceed anything we have seen in the past," said Collins, who believes the growth will be driven by continuing technological advancements in many fields including medicine, material science, and energy production and the ongoing globalization of business as new markets open up in developing countries. 

Collins also sees a coming revitalization of American manufacturing through entrepreneurial innovation and breakthroughs in technology.

"Science-based technology companies will continue to change the world. Chemistry and biochemistry will drive many of these companies," said Collins. "Your goal is to go forward and truly become our greatest generation ever."

Collins encouraged the graduates to find something they are passionate about and to pursue it with all their energy and determination.

"Whatever you decide to do, be the absolute best at it and keep challenging yourself," Collins encouraged. "Always be prepared, but be bold and think big."

A prepared text of Dr. Collins' commencement address is available on CEM's website at www.cem.com.

CEM Corporation, a private company based in Matthews, North Carolina, is the leading global company specializing in scientific solutions for critical laboratory applications. The Company has subsidiaries in the United Kingdom, Germany, Italy, France, and Japan, as well as a global network of distributors. CEM designs and manufactures systems for bioscience applications, life sciences, analytical laboratories and processing plants worldwide. The Company's products are used in many industries including pharmaceutical, biotech, chemical and food processing, as well as academic research.


'/>"/>
SOURCE CEM Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. RIFM Board Names New President
2. Ultragenyx Appoints Shalini Sharp as Chief Financial Officer and Senior Vice President, Finance
3. Hospira Names John B. Elliot Senior Vice President of Operations
4. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
5. Health Diagnostic Laboratory Names Scott Blackwell Vice President of Corporate Culture
6. Intarcia Announces Expanded Appointment for Kurt Graves as Chairman, President and Chief Executive Officer
7. Society of Interventional Radiology Names Marshall Hicks, M.D., FSIR, as 2012-13 President
8. Fitzsimons Redevelopment Authority Names New President & CEO
9. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
10. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
11. Neuralstem President and CEO to Present at BIO CEO & Investor Conference 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
Breaking Biology Technology:
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:5/24/2016)... superior patient care by providing unparalleled technology to leaders of the medical imaging industry. ... recently added to the range of products distributed by Ampronix. Photo - ... ... ... ...
Breaking Biology News(10 mins):